profile-img
Andy Biotech

@AndyBiotech

#Biotech Investor | Recovering Scientist | May have L/S position in names mentioned | Opinions are strictly my own and not intended as investment advice

calendar_today10-07-2012 19:50:09

9,9K Tweets

78,1K Followers

746 Following

Andy Biotech(@AndyBiotech) 's Twitter Profile Photo

$SRPT FDA summary slides today emphasizes the key point that 'Patients likely have only one chance to receive an AAV vector-based gene therapy for DMD', which could drive the panel discussion today to wait for Ph3 data that will be available later this year.

$SRPT FDA summary slides today emphasizes the key point that 'Patients likely have only one chance to receive an AAV vector-based gene therapy for DMD', which could drive the panel discussion today to wait for Ph3 data that will be available later this year.
account_circle